Introduction
Dr. Marco Goeijenbier, Spaarne Hospitaal, ESWI Member, chair IDC
Round 1: Why influenza and diabetes specifically? The evidence for severe influenza in persons living with diabetes.
Dr. Kirsty Short, ESWI Associate member, University of Queensland, Australia
Dr. Felix Wensveen, Rijeka University, Croatia
Round 2: Is there a bidrectional relationship between influenza and diabetes?
Dr. Katina Hulme, Amsterdam UMC, The Netherlands
Dr. Rik Endeman, Erasmus University Rotterdam, The Netherlands
Dr. Marco Goeijenbier, Spaarne Hospitaal, ESWI Member, chair IDC
Round 3: What role does influenza virus vaccination play in diabetes progression or even occurrence?
Prof. Mads Kjølby, Aarhus University, Denmark
Round 4: How can we improve Vaccination uptake in the consulting room
Dr. Wesley de Jong, Erasmus MC, The Netherlands
Prof. Joao Filipe Raposo, IDF Europe Board Member, and Medical Director for the Associação Protectora dos Diabéticos de Portugal (APDP)
Round table discussion
Dr. Marco Goeijenbier, Spaarne Hospitaal, ESWI Member, chair IDC
Dr. Katina Hulme, Amsterdam UMC, The Netherlands
Dr. Rik Endeman, Erasmus University Rotterdam, The Netherlands
Dr. Kirsty Short, ESWI Associate member, University of Queensland, Australia
Dr. Felix Wensveen, Rijeka University, Croatia
Prof. Mads Kjølby, Aarhus University, Denmark
Dr. Wesley de Jong, Erasmus MC, The Netherlands
Prof. Joao Filipe Raposo, IDF Europe Board Member, and Medical Director for the Associação Protectora dos Diabéticos de Portugal (APDP)
------
This session is organised by ESWI and the Influenza Diabetes Community. Made possible thanks to IFPMA.
Introduction
Peter Openshaw, ESWI Board member, Imperial College London, United Kingdom
It Could Be You: The Unheard Voices of RSV and Influenza From a Specialist Perspective
Panel discussion with Marco Goeijenbier, Krzysztof Narkiewicz and David B Price
Case Series to Identify Who Is at Risk of Chronic Complications and Why We Should Think Beyond Just the Acute Infection
Panel discussion with Marco Goeijenbier, Krzysztof Narkiewicz and David B Price
Unmet Needs in the Management of Respiratory Viral Diseases and Emerging Vaccine Strategies
Panel discussion with Marco Goeijenbier, Krzysztof Narkiewicz and David B Price
Closing Remarks and Q&A
Peter Openshaw, ESWI Board member, Imperial College London, United Kingdom
A welcome word from the Conference Chairs
Ab Osterhaus, ESWI Chair, TiHo, Germany
Colin Russell, ESWI Board Member, Academic Medical Center, The Netherlands
Marco Goeijenbier, ESWI Board Member, Spaarne Gasthuis,The Netherlands
Passing the baton: Introducing ESWI's new Executive Committee
Ab Osterhaus, ESWI Chair, TiHo, Germany
Colin Russell, ESWI Board Member, Academic Medical Center, The Netherlands
Marco Goeijenbier, ESWI Board Member, Spaarne Gasthuis,The Netherlands
Ted van Essen, ESWI Board Member, The Netherlands
Stefania Maggi, ESWI Board Member, National Research Council of Italy, Italy
Scientific Keynote: “Immune Responses to Respiratory Viruses and ‘Long-Haul’ Disease”
Peter Openshaw, ESWI Board Member, Imperial College London, United Kingdom
Launch of the ESWI Early Career Scientists Community
Debby Van Riel, Erasmus MC, The Netherlands
Increasing HbA1c is associated with reduced CD8+ T cell functionality in response to influenza virus in a TCR-dependent manner in individuals with diabetes mellitus
Katina Hulme, Amsterdam UMC, Netherlands
Severity of 1st, 2nd, and 3rd SARS-CoV-2 infections
Aubree Gordon, University of Michigan, United States of America
Cost-effectiveness of reduced viral transmission with baloxavir antiviral treatment for seasonal and pandemic influenza in the United Kingdom
Hassan Zaraket, Roche Products Ltd, United Kingdom
RSV and other respiratory viruses in older adults with ARI in the outpatient setting in Germany in the 2022/23 season
Alan Marijam, GSK, Belgium
Uptake of the Live Attenuated Influenza Vaccine (LAIV) in children during the 2013 to 2021 flu seasons in England: a retrospective observational study using CPRD-HES data
Christine Masters, AstraZeneca, United Kingdom
RSV epidemiology and health care resource use associated with RSV patients in inpatient care in Switzerland 2016-2021
Michael Stucki, ZHAW Zurich University of Applied Sciences, Switserland
Infants not exposed to bronchioloitis during the 2020 lockdown present a reduction of subsequent wheezing illnesses: a population database analyses
Riccardo Boracchini, University of Milano-Bicocca, Italy
Repeat vaccination with recombinant or cell-based influenza vaccines in healthcare personnel redirected antibody responses from egg-adapted epitopes in the hemagglutinin of A(H3N2) influenza virus
Feng Liu, Centers for Disease Control and Prevention, United States of America
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillance
Sarah Denayer, Sciensano, Belgium
Burden of respiratory syncytial virus (RSV) disease in older adults with acute respiratory infection (ARI) in Europe during the 2021/2022 season
Sílvia Narejos Pérez, CAP CENTELLES, Spain
Highly pathogenic avian influenza A virus (HPAIV) H5N1 infection in two European grey seals (Halichoerus grypus) with encephalitis
Monica Mirolo, University of veterinary medicine hannover, foundation, Germany
The response of Adult and Paediatric Nasal Epithelial cells to Influenza A Viral Infection
Neve Collins, University of Queensland, Australia
In vitro and in vivo differences in neurovirulence between D614G, Delta and Omicron BA.1 SARS-CoV-2 variants
Lisa Bauer, Erasmus MC, The Netherlands
PM-GBL-RSA-AGND-230002 07/2023
©2023 GSK group of companies or its licensor GlaxoSmithKline
Biologicals SA. Rixensart, Belgium
Ben Cowling, University of Hong Kong, Hong Kong S.A.R.
Wenqing Zhang, World Health Organization, Switzerland
Highlights of the conference from the Chairs
Ab Osterhaus, ESWI Chair, TiHo, Germany
Colin Russell, ESWI Board Member, Academic Medical Center, The Netherlands
Marco Goeijenbier, ESWI Board Member, Spaarne Gasthuis,The Netherlands
Presentation of the ESWI lifetime achievement award
Ab Osterhaus, ESWI Chair, TiHo, Germany
Colin Russell, ESWI Board Member, Academic Medical Center, The Netherlands
Announcement ESWI Conference 2025
Colin Russell, ESWI Board Member, Academic Medical Center, The Netherlands